牛牛AI助理已提取核心訊息
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
Merck & Co. officer Dean Li is set to sell 14,702 shares of the company's common stock on February 9, 2024, according to a recent filing. The shares, valued at approximately $1.85 million, were acquired on the same date through the exercise of options under a registered plan. The transaction will be executed by cash payment. No prior sales of securities have been reported by Li in the past three months.
根據最近的一份文件，默沙東公司高管李迪安定於2024年2月9日出售公司14,702股普通股。這些股票價值約185萬美元，於同日通過行使註冊計劃下的期權收購。該交易將通過現金付款執行。在過去的三個月中，李沒有報告過證券的先前銷售情況。
根據最近的一份文件，默沙東公司高管李迪安定於2024年2月9日出售公司14,702股普通股。這些股票價值約185萬美元，於同日通過行使註冊計劃下的期權收購。該交易將通過現金付款執行。在過去的三個月中，李沒有報告過證券的先前銷售情況。
有用
沒用